Article R5121-178-2
…to the Pharmacovigilance Risk Assessment Committee referred to in Article 56 of Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004. The draft protocol is submi…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 41–50 of 51 articles for “Art. 726”
…to the Pharmacovigilance Risk Assessment Committee referred to in Article 56 of Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004. The draft protocol is submi…
Open the article to read the full text in English.
…007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 and clinical trials of advanced therapy medicinal products as defined in 17° of Article L.…
…medicinal products which have been granted a marketing authorisation pursuant to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004, the Agence nationale de séc…
…on value;According to the following scale: Base brackets Rate applicable 0 to €1,725 1.488% From €1,726 to €4,600 0.496% From €4,601 to €34,500 0.248% More than €34,501 0.099%The fee mentioned in the…
…sions of Chapter I of Title II of this Book or by the European Union pursuant to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community proced…
…007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004, and reconstitution of investigational advanced therapy medicinal products; 5° Putting into…
…is of article 80 bis of the General Tax Code, as well as from the second paragraph of II of article 726 of the same code may not be included in the plan. Units in venture capital mutual funds, shares…
…o the Committee for Pharmacovigilance Risk Assessment mentioned in Article 56 of Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004.In collaboration with the Eu…
…007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004, manufactured in France in accordance with specific quality standards and used in a hospita…
Our translations are produced and reviewed for accuracy, but the only legally binding version of French law is the French original. For court, registry or contractual use we offer lawyer-reviewed or sworn certified translations on request.
Articles are synced with Légifrance and updated as soon as a reform is published in the Journal Officiel, so you always read the version in force — and can see when each article was last amended.
Each article is linked to the key court decisions (Cour de cassation, Conseil d'État, courts of appeal) that interpret it, so you can read the text and its case-law application side by side.
Yes — every article has an AI plain-English summary, and you can order a lawyer-reviewed explanation of how it applies to your specific situation, with next steps.
No. Reading and searching the codes is free with no login. Paid services — certified translation and the legal application report — are entirely optional.
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More